Workflow
Zimmer Biomet(ZBH)
icon
Search documents
Zimmer Biomet (ZBH) to Broaden Knee Surgery Line With New Alliance
ZACKS· 2024-06-13 16:37
Zimmer Biomet Holdings, Inc. (ZBH) entered into a limited distribution agreement with Think Surgical Inc. to expand its knee surgery product business. Per the terms of the agreement, Zimmer Biomet will offer Think Surgical's wireless, handheld TMINI - Miniature Robotic System for total knee arthroplasty. More in the News As ZBH's core focus remains on advancing technologies for total knee replacement, this collaboration should help strengthen Zimmer Biomet's position in this market. About TMINI Image Source ...
RevelAi Health and Zimmer Biomet Announce Exclusive Multi-Year Co-Marketing Agreement to Advance Value-Based Care and Health Equity through AI-Powered Technology
Prnewswire· 2024-06-12 12:38
RevelAi Health is a software as a service (SAAS) health technology company that specializes in cutting-edge generative AI population health solutions. RevelAi Health's clinician-validated large language model helps healthcare providers transition seamlessly to value-based care, meeting essential CMS (Centers for Medicare & Medicaid Services) requirements, including Patient Reported Outcome measures and Social Drivers of Health (SDOH) Screening. For more information about this partnership and the technologie ...
Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI® Miniature Handheld Robotic System for Total Knee Arthroplasty
Prnewswire· 2024-06-11 11:30
--TMINI System Complements Company's Flagship ROSA® Robotics Portfolio Featuring Applications for Knee, Hip and Shoulder Arthroplasty-- "We are proud to be the first medtech company to offer two complementary robotic systems for surgeons looking to incorporate robotic assistance while performing a knee replacement," said Dr. Nitin Goyal, Chief Science, Technology and Innovation Officer at Zimmer Biomet. "TMINI addresses surgeon demand for an ergonomic, wireless, handheld robotic system and now, in addition ...
Zimmer Biomet (ZBH) Procedure Recovery Aids Amid Macro Woes
ZACKS· 2024-06-04 17:15
Despite a sizable day rate headwind and difficult year-over-year comps in the first quarter, U.S. sales rose 3.7% year over year. Since the beginning of 2024, procedure volume has been very strong in both Knees and Hips, banking on an improved market scenario. International sales grew 5.4% year over year at a constant exchange rate. All regions benefited primarily from continued growth in the Knee category as well as strong commercial execution and new product uptake. Zimmer Biomet (ZBH) is witnessing volum ...
Zimmer Biomet to Present at the Goldman Sachs 45th Annual Healthcare Conference
Prnewswire· 2024-06-04 11:30
WARSAW, Ind., June 4, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will be presenting at the Goldman Sachs 45th Annual Healthcare Conference on Tuesday, June 11, 2024, at 8:40 a.m. ET. A live webcast of the presentation can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. The webcast will be archived for replay following the conferenc ...
Zimmer Biomet (ZBH) Unlocks Growth Plan for Future Success
ZACKS· 2024-05-30 17:26
Zimmer Biomet Holdings, Inc. (ZBH) recently held its 2024 Investor Day and outlined its exciting long-term growth and value-creation plan as well as its strategic targets. The company provides a path for compelling and long term top-line growth, improved operational profitability, and increased free cash flow generation. In the past five years, Zimmer Biomet experienced a significant metamorphosis, emerging as a more robust enterprise with promising prospects. Being a provider of orthopedics and medical tec ...
Zimmer Biomet Outlines Strategy to Deliver Above Market Growth at 2024 Investor Day
prnewswire.com· 2024-05-29 21:02
Presents Path for Compelling and Durable Topline Growth, Improved Operational Profitability and Increased Free Cash Flow Generation Details New Capital Allocation Priorities and Commitment to Strategic Diversification Announces Strategic Partnership with CBRE, the World's Largest Commercial Real Estate Services and Investment Firm, to Develop and Outfit Orthopedic Ambulatory Surgery Centers (ASC) in the U.S. WARSAW, Ind. and NEW YORK, May 29, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ...
Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?
zacks.com· 2024-05-29 14:46
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over ...
Zimmer Biomet Announces 2024 Investor Day
prnewswire.com· 2024-05-20 12:30
WARSAW, Ind., May 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it will host an Investor Day on Wednesday, May 29, 2024, at 1:00 p.m. E.T. until approximately 4:30 p.m. ET at the New York Stock Exchange in New York City. The event will feature presentations by members of the senior management team, including President and CEO Ivan Tornos and Chief Financial Officer, EVP, Finance, Operations and Supply Chain Suky Upadhyay, ...
Here's Why You Should Retain Zimmer Biomet (ZBH) Stock for Now
Zacks Investment Research· 2024-05-15 14:02
Zimmer Biomet (ZBH) is well-poised to grow in the coming quarters owing to the encouraging business recovery and increased provider capacity driving backlog pull-through. The company also progresses on the four-pillar strategy to expand the Knee business. Further, the global musculoskeletal market's gradual stabilization bodes well for its operations. Meanwhile, unfavorable solvency and currency fluctuations raise concerns for Zimmer Biomet. In the past year, this Zacks Rank #3 (Hold) stock has declined 11% ...